Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22
Phase 31
Phase 42

Trial Status

Completed4
Terminated2
Other1

Role Distribution

Principal Investigator5
Other Roles2
PI Rate71%

Activity Timeline

Clinical Trials (7)

NCT06364774Phase 1/2Active Not Recruiting
ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia
Beta-Thalassemia
PrincipalinvestigatorStart date: 2025-04-14
NCT02443545Phase 4Terminated
Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias
Iron OverloadOther AnemiasSickle Cell Disease
PrincipalinvestigatorStart date: 2015-05-21
NCT02041299Phase 4Terminated
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Iron OverloadOther AnemiasSickle Cell Disease
PrincipalinvestigatorStart date: 2014-04-17
NCT00872170Phase 2/3Completed
Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension
Hypertension, PulmonaryThalassemia
Principalinvestigator
NCT00872339Completed
Assessment of Pain in People With Thalassemia
Thalassemia
Principalinvestigator

Research Network

Collaboration Network

46 collaborators·66 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Charles Quinn, MD

University of Texas, Southwestern Medical Center at Dallas

Moderately Similar
2 trials

Shared therapeutic areas:

Anemia, Sickle CellHypertension, PulmonaryThalassemia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score34%

John Porter, MD

University College, London

Moderately Similar
2 trials

Shared therapeutic areas:

beta-ThalassemiaHypertension, PulmonaryThalassemia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score34%

Alexis Thompson, MD

Children's Memorial Hospital of Chicago

Moderately Similar
2 trials

Shared therapeutic areas:

beta-ThalassemiaIron OverloadThalassemia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score34%

Nancy Olivieri, MD

Toronto General Hospital

Related
2 trials

Shared therapeutic areas:

ThalassemiaHypertension, Pulmonary

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Patricia Giardina, MD

Weill Medical College of Cornell

Related
2 trials

Shared therapeutic areas:

ThalassemiaHypertension, Pulmonary

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Ellis Neufeld, MD, PhD

Boston Children's Hospital

Related
3 trials

Shared therapeutic areas:

ThalassemiaHypertension, Pulmonary

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)+1 more
Collaborated on 2 trials
Similarity Score28%

Claudia Morris, MD

Children's Hospital and Research Institute Oakland

Related
1 trials

Shared therapeutic areas:

Hypertension, PulmonaryThalassemia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Ali Taher, MD

American University of Beirut Medical Center- Lebannon

Related
1 trials

Shared therapeutic areas:

Hypertension, PulmonaryThalassemia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Thomas Coates, MD

Children's Hospital Los Angeles

Related
2 trials

Shared therapeutic areas:

Anemia, Sickle CellThalassemia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Ellis Neufeld, MD

Boston Children's Hospital

Related
6 trials

Shared therapeutic areas:

beta-ThalassemiaThalassemia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT06364774Phase 1/2PrincipalInvestigator

ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia

Beta-Thalassemia
Active Not Recruiting
NCT02443545Phase 4PrincipalInvestigator

Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias

Iron OverloadOther AnemiasSickle Cell Disease
Terminated
NCT02041299Phase 4PrincipalInvestigator

Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias

Iron OverloadOther AnemiasSickle Cell Disease
Terminated
NCT00661804StudyChair

Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study

Thalassemia
Completed
NCT00872170Phase 2/3PrincipalInvestigator

Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension

Hypertension, PulmonaryThalassemia
Completed
NCT00872339PrincipalInvestigator

Assessment of Pain in People With Thalassemia

Thalassemia
Completed
NCT00872833StudyChair

Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions

Thalassemia
Completed

All 7 trials loaded